With antibiotic use receding in poultry production, vaccines are playing a larger role in the success of a poultry operation.
As part of the 2019 Poultry Tech Summit in Atlanta, Dr. Holly Sellers, a professor at the University of Georgia’s (UGA) College of Veterinary Medicine’s Poultry Diagnostic and Research Center, will speak about the future vaccine’s development and commercialization.
Making new vaccines
As demands for antibiotic-free and no-antibiotics-ever increases in poultry production around the U.S. and the world, the importance of vaccines grows. However, vaccines can take years to develop and must be commercially viable in order for the manufacturers to invest the resources to research and make the drug. Vaccine makers need to be aware of the present market and what disease challenges they may or may not be facing in the near future.
In her presentation, Sellers will speak about what diseases and syndromes may be ripe for new vaccines in 2019 and beyond. She will also share insights in to the process for developing and commercializing poultry vaccines.
The Poultry Diagnostic and Research Center (PDRC) is dedicated to the advancement of poultry medicine. Holly Sellers pursues clinical and molecular virology research with an emphasis on viruses that cause respiratory, enteric and musculoskeletal diseases in poultry. Her research has led to 12 invention disclosures and five U.S. patents, with another application pending and a multitude of foreign patents and applications. Sellers’ technologies have been made available to the industry through more than 20 license agreements, leading to four commercial poultry vaccines as well as numerous autogenous vaccines.
The Poultry Tech Summit is presented by WATT Global Media in collaboration with the Georgia Tech Research Institute, USPOULTRY, and the University of Georgia with support from the World’s Poultry Science Association. The event will be held November 20-22 at the Georgia Tech Hotel & Conference Center. Registration is now open.